AstraZeneca shares slide 1.86% in weak London market
Updated
Updated · MarketWatch · May 7
AstraZeneca shares slide 1.86% in weak London market
6 articles · Updated · MarketWatch · May 7
The stock closed at £133.14 on Thursday as the FTSE 100 fell 1.55% to 10,276.95.
AstraZeneca underperformed the broader market during a generally poor trading session for UK equities.
The shares finished 15.37% below their 52-week high of £157.32 reached on February 18, while trading volume of 2.2 million was below the 50-day average of 2.6 million.
Is AstraZeneca's stock just a casualty of market turmoil, or does a surprise FDA ruling signal deeper troubles?
After a key cancer drug's rejection, can AstraZeneca's pipeline still deliver its ambitious $80 billion revenue goal?